The 30 references in paper A. Lyanguzov V, L. Kolotilov V., T. Zagoskina P., А. Лянгузов В., Л. Колотилов В., Т. Загоскина П. (2009) “Рабдомиолиз у больных гемобластозами в процессе интенсивной химиотерапии // Rhabdomyolysis in Patients with Hemoblastoses during Intensive Chemotherapy” / spz:neicon:reanimatology:556

1
Румянцев А. Г., Масчан А. А., Самочатова Е. В.Сопроводительная терапия и контроль инфекций при гематологических и онкологических заболеваниях. М.: Медпрактика; 2006.
(check this in PDF content)
2
Волкова М. А.(ред.) Клиническая онкогематология. М.: Медицина; 2001.
(check this in PDF content)
3
Jackson S. R., Tweeddale M. G., Barnett M. J. et al.Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant. 1998; 21 (7): 697—704.
(check this in PDF content)
4
Evison J., Rickenbacher P., Ritz R. et al.Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med. Wkly 2001; 131 (47—48): 681—686.
(check this in PDF content)
5
Hinds C. J., Martin R., Quinton P. Intensive care for patiens with medical complications of haematological malignancy: is it worth it? Schweiz. Med. Wochenschr. 1998; 128 (39): 1467—1473.
(check this in PDF content)
6
Poletti V., Trisolini R., Tura S.Pulmonary disease in patients with hematologic malignancies. Sarcoidosis Vasc. Diffuse Lung Dis. 2002; 19 (1): 29—45.
(check this in PDF content)
7
Gabow P. A., Kaehny W. D., Kelleher S. P. The spectrum of rhabdomyolysis. Medicine; 1982.
(check this in PDF content)
8
Sauret J. M., Marinides G., Wang G. K.Rhabdomyolysis. Am. Fam. Physician. 2002; 65 (5): 907—912.
(check this in PDF content)
9
Заугольников В. С., Теплова Н. Н.Рабдомиолиз в клинической практике. Вятский мед. вестн. 2002; 3: 7—11.
(check this in PDF content)
10
Farmer Christopher J.Rhabdomyolysis In: Civetta M. (ed.) Critical Care. 3rd ed. Philadelphia (PA): Lippincott-Raven Publishers; 1997. 2195—2202.
(check this in PDF content)
11
Margolis D., Ross E., Miller K. B.Rhabdomyolysis associated with highdose cytarabine. Cancer Treat. Rep. 1987; 71 (12): 1325—1326.
(check this in PDF content)
12
Truica C. I., Frankel S. R.Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: case report and review of literature. Am. J. Hematol. 2002; 70 (4): 320—323.
(check this in PDF content)
13
Blanco J. R., Zabalza M., Salcedo J. et al.Rhabdomyolysis of infectious and noninfectious causes. South Med. J. 2002; 95 (5): 542—544.
(check this in PDF content)
14
Larner A. J.Potassium depletion and rhabdomyolysis. BMJ 1994; 308 (6921): 136.
(check this in PDF content)
15
Shintani S., Shiigai T., Tsukagoshi H. Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment. Eur. Neurol. 1991; 31 (6): 396—398.
(check this in PDF content)
16
Rossi M. R., Longoni D. V., Rovelli A. M., Uderzo C. Severe rhabdomyolysis, hyperthermia and shock after amphotericin B colloidal dispersion in an allogeneic bone marrow transplant recipient. Pediatr. Infect. Dis. J. 2000; 19 (2): 172—173.
(check this in PDF content)
17
Ruiz?Contreras J., Rodriguez R., Gomez de Quero P. et al.Severe hypokalemia and rhabdomyolysis associated with itraconazole therapy. Pediatr. Infect. Dis. J. 2003; 22 (11): 1024—1025.
(check this in PDF content)
18
D'Agnillo F., Wood F., Porras C. et al.Effects of hypoxia and glutathione depletion on hemoglobin- and myoglobin-mediated oxidative stress toward endothelium. Biochim. Biophys. Acta 2000; 1495 (2): 150—159.
(check this in PDF content)
19
Iwata M., Zager R. A. Myoglobin inhibits proliferation of cultured human proximal tubular (HK-2) cells. Kidney Int. 1996; 50 (3): 796—804.
(check this in PDF content)
20
Reeder B. J., Sharpe M. A., Kay A. D. et al.Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid haemorrhage. Biochem. Soc. Trans. 2002; 30 (4): 745—748.
(check this in PDF content)
21
Чернов В. Н., Химичев В. Г., Бабиев В. Ф. Сывороточный МГ как показатель эндотоксикоза при острой непроходимости тонкой кишки. Хирургия 1999; 4: 43—46.
(check this in PDF content)
22
Титов В. Н., Кошкина Т. И., Волкова Е. И.Миоглобин крови: диагностическое значение и методы исследования. Клин. лаб. диагностика 1993; 3: 3—10.
(check this in PDF content)
23
Margolis D. Rhabdomyolysis associated with high-dose cytarabine. Cancer Treat. Rep. 1987; 71 (12): 1325—1326.
(check this in PDF content)
24
Truica C. I., Frankel S. R.Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: case report and review of literature. Am. J. Hematol. 2002; 70 (4): 320—323.
(check this in PDF content)
25
Переводчикова Н. И.(ред.) Химиотерапия опухолевых заболеваний. Краткое руководство. М.; 2000.
(check this in PDF content)
26
Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981; 47 (1): 207—214.
(check this in PDF content)
27
Knochel J. P, Schlein E. M. On the mechanism of rhabdommyolisis in potassium depletion. J. Clin. Invest. 1972; 51 (7): 1750—1758.
(check this in PDF content)
28
Hund E.Myopathy in critically ill patients. Crit. Care Med. 1999; 27 (11): 2544—2547.
(check this in PDF content)
29
Motomura M. Critical illness polyneuropathy and myopathy. Rinsho Shinkeigaku. 2003; 43 (11): 802—804.
(check this in PDF content)
30
Burnham E. L., Moss M., Ziegler T. R. Myopathies in critical illness: characterization and nutritional aspects. J. Nutr. 2005; 135 (7): 1818—1823. Поступила 25.03.09 22ndESICM Annual Congress October, 11—14, Austria, Vienna
(check this in PDF content)